Cameron Turtle

CIK 1758363 · Chief Executive Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$50.42M

Companies

6

Total Filings

44

Lifetime Open-Market Net

-$17.78M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SYRE Chief Executive Officer 597,540 $80.79 $48.28M -$5.94M 12 2026-06-03
DMRA Director $20.78 $0 1 2026-03-25
ORKA Director $69.89 $0 1 2025-06-03
Spyre Therapeutics, Inc. (AGLE) Delisted Chief Executive Officer 746,507 $12.01 $8.97M $0 1 2023-11-27
BBIO See Remarks 32,068 $66.80 $2.14M -$3.63M 15 2020-12-29
Eidos Therapeutics, Inc. (EIDX) Delisted Chief Business Officer 73,159 -$8.21M 13 2020-12-16

Recent Filings · Page 5 of 5

44 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-11-22 Eidos Therapeutics, Inc. (EIDX) Delisted Sell (S) −10,000 -$557.5K EDGAR
2019-09-06 Eidos Therapeutics, Inc. (EIDX) Delisted Sell (S) −5,000 -$207.9K EDGAR
2019-07-03 BBIO Exer (M) +12,630 $0 EDGAR
2019-06-06 Eidos Therapeutics, Inc. (EIDX) Delisted Mixed −7,150 -$282.2K EDGAR
Showing 4144 of 44
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.